[4]DUPLOYEZ N, WILLEKENS C, MARCEAU-RENAUT A, et al. 2015. Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors. Expert Rev Hematol [J], 8: 43-56. [5]DOHNER H, ESTEY E, GRIMWADE ...
Impact of different therapeutic regimen on prognosis in CEBPAbZIP-infacute myeloid leukemia(摘要号:4274) 报告时间: 2024年12月9日,星期一,下午6:00至8:00(美国西部时间) 2024年12月10日,星期二,上午10:00至12:00(北京时间)...
AML-033: Prognosis of Vascular Endothelial Growth Factor Gene Polymorphism in Egyptian Patients with Acute Myeloid LeukemiaVEGFgene polymorphismAMLVEGF rs699947 SNPThe main target of this study is to investigate the relationship between VEGF gene polymorphism (rs699947) with AML. Angiogenesis is an ...
Acute myeloid leukemia (AML) is a type of blood cancer that starts in your bone marrow, which is the soft inner part of your bones where all your blood cells are made. AML usually begins in cells that turn into white blood cells but can also start in other blood-forming cells. When ...
Impact of different therapeutic regimen on prognosis in CEBPAbZIP-infacute myeloid leukemia(摘要号:4274) 报告时间: 2024年12月9日,星期一,下午6:00至8:00(美国西部时间) 2024年12月10日,星期二,上午10:00至12:00(北京时间) 第一作者:潘佳佳 ...
MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes Cancer Res 1997 57: 117–122 CAS PubMed Google Scholar Strout M, Marcucci G, Bloomfield C, Caligiuri M . The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-...
Until recently, acute myeloid leukemia (AML) patients used to have limited treatment options, depending solely on cytarabine + anthracycline (7 + 3) intensive chemotherapy and hypomethylating agents. Allogeneic stem cell transplantation (Allo
innovative immunomodulatory agents, all aimed at striking a delicate balance between averting GvHD and safeguarding the beneficial graft-versus-leukemia (GvL) effects (Malard et al.2023; Choi et al.2010; Cooke et al.2017). Splenomegaly is associated with a poor prognosis and primary graft failure...
Genomic classification and prognosis in acute myeloid leukemia. N. Engl J Med. 2016;374:2209–21. 3. Sasaki K, Ravandi F, Kadia TM, DiNardo CD, Short NJ, Borthakur G, et al. De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the ...
Background Allogeneic stem cell transplantation (SCT) is a potentially curative treatment for patients with high-risk acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, relapsed disease is a major cause of treatment failure and death after SCT which is d...